المؤلفون: Benjamin, Emelia J, Al‐Khatib, Sana M, Desvigne‐Nickens, Patrice, Alonso, Alvaro, Djoussé, Luc, Forman, Daniel E, Gillis, Anne M, Hendriks, Jeroen ML, Hills, Mellanie True, Kirchhof, Paulus, Link, Mark S, Marcus, Gregory M, Mehra, Reena, Murray, Katherine T, Parkash, Ratika, Piña, Ileana L, Redline, Susan, Rienstra, Michiel, Sanders, Prashanthan, Somers, Virend K, Van Wagoner, David R, Wang, Paul J, Cooper, Lawton S, Go, Alan S

المصدر: Journal of the American Heart Association, vol 10, iss 16

مصطلحات موضوعية: Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Clinical Research, Comparative Effectiveness Research, Cardiovascular, Prevention, Clinical Trials and Supportive Activities, Heart Disease, Stroke, Good Health and Well Being, Animals, Anti-Arrhythmia Agents, Atrial Fibrillation, Biomedical Research, Body Composition, Cardiac Rehabilitation, Comorbidity, Disease Progression, Health Priorities, Health Services Needs and Demand, Healthy Lifestyle, Humans, National Heart, Lung, and Blood Institute (U.S.), Needs Assessment, Recurrence, Research Design, Risk Assessment, Risk Factors

وصف الملف: application/pdf

العلاقة: qt9r84k5c2; https://escholarship.org/uc/item/9r84k5c2Test

الإتاحة: https://escholarship.org/uc/item/9r84k5c2Test

المؤلفون: Piña, Ileana L, Abdelhamid, Magdy

المساهمون: Seferović, Petar M., Coats, Andrew J.S., Filippatos, Gerasimos, Anker, Stefan D., Bauersachs, Johann, Rosano, Giuseppe

المصدر: The ESC Textbook of Heart Failure ; page 447-458 ; ISBN 0198891628 9780198891628 9780191996399

الإتاحة: https://doi.org/10.1093/med/9780198891628.003.0041Test
https://academic.oup.com/book/chapter-pdf/56772859/book_55331_section_428854660.ag.pdfTest

المؤلفون: Reza, Nosheen, Tahhan, Ayman Samman, Mahmud, Nadim, DeFilippis, Ersilia M, Alrohaibani, Alaaeddin, Vaduganathan, Muthiah, Greene, Stephen J, Ho, Annie Hang, Fonarow, Gregg C, Butler, Javed, O’Connor, Christopher, Fiuzat, Mona, Vardeny, Orly, Piña, Ileana L, Lindenfeld, JoAnn, Jessup, Mariell

المصدر: Circulation Heart Failure, vol 13, iss 8

مصطلحات موضوعية: Biomedical and Clinical Sciences, Medical Physiology, Cardiovascular Medicine and Haematology, Cardiovascular, Heart Disease, Clinical Research, Clinical Trials and Supportive Activities, Gender Equality, Authorship, Cardiology, Europe, Female, Humans, Manuscripts, Medical as Topic, Publishing, United States, Women, clinical trial, guideline, heart failure, publications, Biochemistry and Cell Biology, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology

وصف الملف: application/pdf

العلاقة: qt8vr3z7q0; https://escholarship.org/uc/item/8vr3z7q0Test

الإتاحة: https://escholarship.org/uc/item/8vr3z7q0Test

المؤلفون: Keteyian, Steven J, Piña, Ileana L

المصدر: Cardiology Articles

العلاقة: https://scholarlycommons.henryford.com/cardiology_articles/1143Test; http://sfxhosted.exlibrisgroup.com/hfhs?sid=Entrez:PubMed&id=pmid:37775705Test

الإتاحة: https://scholarlycommons.henryford.com/cardiology_articles/1143Test
http://sfxhosted.exlibrisgroup.com/hfhs?sid=Entrez:PubMed&id=pmid:37775705Test

المؤلفون: Butler, Javed, Khan, Muhammad Shahzeb, Friede, Tim, Jankowska, Ewa A., Fabien, Vincent, Goehring, Udo‐Michael, Dorigotti, Fabio, Metra, Marco, Piña, Ileana L., Coats, Andrew J. S., Rosano, Giuseppe, Comin‐Colet, Josep, Van Veldhuisen, Dirk J., Filippatos, Gerasimos S., Anker, Stefan D., Ponikowski, Piotr

العلاقة: Butler, Javed, Khan, Muhammad Shahzeb, Friede, Tim, Jankowska, Ewa A., Fabien, Vincent, Goehring, Udo‐Michael, Dorigotti, Fabio, Metra, Marco, Piña, Ileana L., Coats, Andrew J. S., Rosano, Giuseppe, Comin‐Colet, Josep, Van Veldhuisen, Dirk J., Filippatos, Gerasimos S., Anker, Stefan D. and Ponikowski, Piotr (2022) Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency. European Journal of Heart Failure, 24 (5). pp. 821-832. doi:10.1002/ejhf.2478 ISSN 1879-0844.

الإتاحة: https://doi.org/10.1002/ejhf.2478Test
https://wrap.warwick.ac.uk/163975Test/

المؤلفون: Anker, Stefan D., Ponikowski, Piotr, Khan, Muhammad Shahzeb, Friede, Tim, Jankowska, Ewa A., Fabien, Vincent, Goehring, Udo‐Michael, Metra, Marco, Piña, Ileana L., Coats, Andrew J. S., Rosano, Giuseppe, Dorigotti, Fabio, Comin‐Colet, Josep, Van Veldhuisen, Dirk J., Filippatos, Gerasimos S., Butler, Javed

مصطلحات موضوعية: RC Internal medicine

وصف الملف: application/pdf

العلاقة: https://wrap.warwick.ac.uk/164791/1/WRAP-Responder-improvement-6-min-walk-ferric-heart-failure-ejection-fraction-iron-2022.pdfTest; Anker, Stefan D., Ponikowski, Piotr, Khan, Muhammad Shahzeb, Friede, Tim, Jankowska, Ewa A., Fabien, Vincent, Goehring, Udo‐Michael, Metra, Marco, Piña, Ileana L., Coats, Andrew J. S., Rosano, Giuseppe, Dorigotti, Fabio, Comin‐Colet, Josep, Van Veldhuisen, Dirk J., Filippatos, Gerasimos S. and Butler, Javed (2022) Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency. European Journal of Heart Failure, 24 (5). pp. 833-842. doi:10.1002/ejhf.2491 ISSN 1879-0844.

الإتاحة: https://doi.org/10.1002/ejhf.2491Test
https://wrap.warwick.ac.uk/164791Test/
https://wrap.warwick.ac.uk/164791/1/WRAP-Responder-improvement-6-min-walk-ferric-heart-failure-ejection-fraction-iron-2022.pdfTest

المؤلفون: Butler, Javed, Anker, Stefan D., Siddiqi, Tariq Jamal, Coats, Andrew J. S., Dorigotti, Fabio, Filippatos, Gerasimos, Friede, Tim, Göhring, Udo‐Michael, Kosiborod, Mikhail N., Lund, Lars H., Metra, Marco, Moreno Quinn, Carol, Piña, Ileana L., Pinto, Fausto J., Rossignol, Patrick, Szecsödy, Peter, Van Der Meer, Peter, Weir, Matthew, Pitt, Bertram

مصطلحات موضوعية: QD Chemistry, QP Physiology, RC Internal medicine

وصف الملف: application/pdf

العلاقة: https://wrap.warwick.ac.uk/160977/1/WRAP-patiromer-management-hyperkalaemia-patients-receiving-renin%E2%80%93angiotensin%E2%80%93aldosterone-system-inhibitors-heart-failure-2021.pdfTest; Butler, Javed, Anker, Stefan D., Siddiqi, Tariq Jamal, Coats, Andrew J. S., Dorigotti, Fabio, Filippatos, Gerasimos, Friede, Tim, Göhring, Udo‐Michael, Kosiborod, Mikhail N., Lund, Lars H., Metra, Marco, Moreno Quinn, Carol, Piña, Ileana L., Pinto, Fausto J., Rossignol, Patrick, Szecsödy, Peter, Van Der Meer, Peter, Weir, Matthew and Pitt, Bertram (2022) Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure : design and rationale of the DIAMOND trial. European Journal of Heart Failure, 24 (1). pp. 230-238. doi:10.1002/ejhf.2386 ISSN 1388-9842.

الإتاحة: https://doi.org/10.1002/ejhf.2386Test
https://wrap.warwick.ac.uk/160977Test/
https://wrap.warwick.ac.uk/160977/1/WRAP-patiromer-management-hyperkalaemia-patients-receiving-renin%E2%80%93angiotensin%E2%80%93aldosterone-system-inhibitors-heart-failure-2021.pdfTest

المؤلفون: Butler, Javed, Anker, Stefan D., Siddiqi, Tariq Jamal, Coats, Andrew J.S., Dorigotti, Fabio, Filippatos, Gerasimos, Friede, Tim, Göhring, Udo-Michael, Kosiborod, Mikhail N., Lund, Lars H., Metra, Marco, Moreno Quinn, Carol, Piña, Ileana L., Pinto, Fausto J., Rossignol, Patrick, Szecsödy, Peter, Van Der Meer, Peter, Weir, Matthew, Pitt, Bertram

مصطلحات موضوعية: Hyperkalaemia, Heart failure, Trial design, Adherence, Mineralocorticoid receptor antagonists, Renin- angiotensin- aldosterone system inhibitors, Patiromer, Potassium, Cardiovascular Medicine, Health Sciences

وصف الملف: application/pdf

العلاقة: Butler, Javed; Anker, Stefan D.; Siddiqi, Tariq Jamal; Coats, Andrew J.S.; Dorigotti, Fabio; Filippatos, Gerasimos; Friede, Tim; Göhring, Udo-Michael; Kosiborod, Mikhail N.; Lund, Lars H.; Metra, Marco; Moreno Quinn, Carol; Piña, Ileana L.; Pinto, Fausto J.; Rossignol, Patrick; Szecsödy, Peter; Van Der Meer, Peter; Weir, Matthew; Pitt, Bertram (2022). "Patiromer for the management of hyperkalaemia in patients receiving renin- angiotensin- aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial." European Journal of Heart Failure 24(1): 230-238.; https://hdl.handle.net/2027.42/171557Test; European Journal of Heart Failure; Seliger SL. Hyperkalemia in patients with chronic renal failure. Nephrol Dial Transplant. 2019; 34 ( Suppl 3 ): iii12 - 8.; Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016; 18: 891 - 975.; ClinicalTrials.gov. Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone (REALIZE- K). [cited 2021 Sep 19]. Available from: https://clinicaltrials.gov/ct2/show/NCT04676646Test.; ClinicalTrials.gov. Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure (PRIORITIZE HF). [cited 2021 Aug 19]. Available from: https://clinicaltrials.gov/ct2/show/results/NCT03532009Test.; US Food and Drug Administration. Lokelma prescribing information. 2018 [cited 2021 Aug 19]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207078s000lbl.pdfTest.; Rossignol P, Lainscak M, Crespo- Leiro MG, Laroche C, Piepoli MF, Filippatos G, et al.; Heart Failure Long- Term Registry Investigators Group. Unravelling the interplay between hyperkalaemia, renin- angiotensin- aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC- HFA- EORP Heart Failure Long- Term Registry. Eur J Heart Fail. 2020; 22: 1378 - 89.; Savarese G, Carrero JJ, Pitt B, Anker SD, Rosano GMC, Dahlström U, et al. Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11- 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail. 2018; 20: 1326 - 34.; Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, et al.; Heart Failure Association of the ESC. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long- Term Registry. Eur J Heart Fail. 2013; 15: 1173 - 84.; Beusekamp JC, Tromp J, van der Wal HH, Anker SD, Cleland JG, Dickstein K, et al. Potassium and the use of renin- angiotensin- aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT- CHF. Eur J Heart Fail. 2018; 20: 923 - 30.; Cooper LB, Benson L, Mentz RJ, Savarese G, DeVore AD, Carrero JJ, et al. Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry. Eur J Heart Fail. 2020; 22: 1390 - 8.; Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, et al. Hyperkalemia after initiating renin- angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project. J Am Heart Assoc. 2017; 6: e005428.; Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016; 134: e282 - 93.; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42: 3599 - 726.; US Food and Drug Administration. FDA Drug Safety Communication: FDA recommends separating dosing of potassium- lowering drug sodium polystyrene sulfonate (Kayexalate) from all other oral drugs. 2017 September 6 [cited 2021 Aug 19]. Available from: https://www.fda.gov/drugs/drugTest- safety- and- availability/fda- drug- safety- communication- fda- recommends- separating- dosing- potassium- lowering- drug- sodium.; Pitt B, Bakris GL, Bushinsky DA, Garza D, Mayo MR, Stasiv Y, et al. Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors. Eur J Heart Fail. 2015; 17: 1057 - 65.; Pitt B, Bushinsky DA, Kitzman DW, Ruschitzka F, Metra M, Filippatos G, et al.; Patiromer- 204 Investigators. Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease. ESC Heart Fail. 2018; 5: 257 - 66.; Pitt B, Anker SD, Bushinsky DA, Kitzman DW, Zannad F, Huang IZ; PEARL- HF Investigators. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double- blind, placebo- controlled study in patients with chronic heart failure (the PEARL- HF) trial. Eur Heart J. 2011; 32: 820 - 8.; Pocock SJ, Ariti CA, Collier TJ, Wang D. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J. 2012; 33: 176 - 82.; Cooper LB, Savarese G, Carrero JJ, Szabo B, Jernberg T, Jonsson à , et al. Clinical and research implications of serum versus plasma potassium measurements. Eur J Heart Fail. 2019; 21: 536 - 7.; DeFilippis EM, Reza N, Donald E, Givertz MM, Lindenfeld J, Jessup M. Considerations for heart failure care during the COVID- 19 pandemic. JACC Heart Fail. 2020; 8: 681 - 91.; Trevisan M, Fu EL, Xu Y, Savarese G, Dekker FW, Lund LH, et al. Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care. Eur J Heart Fail. 2021; 23: 1698 - 707.; Beusekamp JC, Tromp J, Cleland JGF, Givertz MM, Metra M, O’Connor CM, et al. Hyperkalemia and treatment with RAAS inhibitors during acute heart failure hospitalizations and their association with mortality. JACC Heart Fail. 2019; 7: 970 - 9.; Ferreira JP, Butler J, Rossignol P, Pitt B, Anker SD, Kosiborod M, et al. Abnormalities of potassium in heart failure: JACC state- of- the- art review. J Am Coll Cardiol. 2020; 75: 2836 - 50.; Trevisan M, de Deco P, Xu H, Evans M, Lindholm B, Bellocco R, et al. Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists. Eur J Heart Fail. 2018; 20: 1217 - 26.; Ouwerkerk W, Voors AA, Anker SD, Cleland JG, Dickstein K, Filippatos G, et al. Determinants and clinical outcome of uptitration of ACE- inhibitors and beta- blockers in patients with heart failure: a prospective European study. Eur Heart J. 2017; 38: 1883 - 90.; Epstein M, Reaven NL, Funk SE, McGaughey KJ, Oestreicher N, Knispel J. Evaluation of the treatment gap between clinical guidelines and the utilization of renin- angiotensin- aldosterone system inhibitors. Am J Manag Care. 2015; 21 ( 11 Suppl ): S212 - 20.

الإتاحة: https://doi.org/10.1002/ejhf.2386Test
https://hdl.handle.net/2027.42/171557Test

المؤلفون: Keteyian, Steven J, Patel, Mahesh, Kraus, William E, Brawner, Clinton A, McConnell, Timothy R, Piña, Ileana L, Leifer, Eric S, Fleg, Jerome L, Blackburn, Gordon, Fonarow, Gregg C, Chase, Paul J, Piner, Lucy, Vest, Marianne, O’Connor, Christopher M, Ehrman, Jonathan K, Walsh, Mary N, Ewald, Gregory, Bensimhon, Dan, Russell, Stuart D, Investigators, HF-ACTION

المصدر: Journal of the American College of Cardiology, vol 67, iss 7

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Heart Disease, Cardiovascular, Clinical Research, Clinical Trials and Supportive Activities, 6.7 Physical, Evaluation of treatments and therapeutic interventions, Good Health and Well Being, Adult, Aged, Cause of Death, Disease Progression, Exercise Test, Female, Follow-Up Studies, Heart Failure, Systolic, Humans, Male, Middle Aged, Oxygen Consumption, Predictive Value of Tests, Prognosis, Stroke Volume, Survival Rate, Time Factors, United States, peak VO2, respiratory exchange ratio

جغرافية الموضوع: 780 - 789

وصف الملف: application/pdf

العلاقة: qt2z10j01r; https://escholarship.org/uc/item/2z10j01rTest

الإتاحة: https://escholarship.org/uc/item/2z10j01rTest

المؤلفون: Felker, G. Michael, Ahmad, Tariq, Anstrom, Kevin J., Adams, Kirkwood F., Cooper, Lawton S., Ezekowitz, Justin A., Fiuzat, Mona, Houston-Miller, Nancy, Januzzi, James L., Leifer, Eric S., Mark, Daniel B., Desvigne-Nickens, Patrice, Paynter, Gayle, Piña, Ileana L., Whellan, David J., O'Connor, Christopher M.

المصدر: Division of Cardiology Faculty Papers

مصطلحات موضوعية: Adrenergic beta-Antagonists, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Biomarkers, Cardiac Resynchronization Therapy, Evidence-Based Medicine, Exercise Therapy, Heart Failure, Systolic, Humans, Mineralocorticoid Receptor Antagonists, Natriuretic Peptide, Brain, Patient Care Planning, Peptide Fragments, Cardiology, Medicine and Health Sciences

وصف الملف: application/pdf

العلاقة: https://jdc.jefferson.edu/cardiologyfp/61Test; https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1060&context=cardiologyfpTest

الإتاحة: https://jdc.jefferson.edu/cardiologyfp/61Test
https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1060&context=cardiologyfpTest